Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current trends in antithrombotic drug and device development

J Fareed1

  • 1Department of Pathology, Loyola University Medical Center, Maywood, IL 60153, USA.

Seminars in Thrombosis and Hemostasis
|January 1, 1996
PubMed
Summary

Recent advancements in understanding thrombosis mechanisms have led to new antithrombotic and anticoagulant drugs. These innovative therapies target hematologic and vascular pathways for improved treatment of thrombotic disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional and Systemic Prothrombotic Biomarkers in Varicose Vein Patients and Healthy Controls.

Journal of vascular surgery. Venous and lymphatic disorders·2016
Same author

Blood Sampled Directly from Varicose Veins Reveals Activation of Inflammatory Processes.

Journal of vascular surgery. Venous and lymphatic disorders·2016
Same author

Do blood constituents in varicose veins differ from the systemic blood constituents?

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2015
Same author

Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.

International angiology : a journal of the International Union of Angiology·2014
Same author

Pharmacological profile of sulodexide.

International angiology : a journal of the International Union of Angiology·2014
Same author

Medical management of patients with peripheral arterial disease.

International angiology : a journal of the International Union of Angiology·2014

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Biotechnology

Background:

  • Significant progress in managing thrombotic and vascular disorders over the past decade.
  • Newer prophylactic and therapeutic strategies for venous thrombosis, myocardial infarction, and stroke have emerged.
  • Understanding molecular mechanisms of thrombosis is key to these advancements.

Purpose of the Study:

  • To review recent developments in antithrombotic and anticoagulant therapies.
  • To highlight the diversity of new agents and their mechanisms of action.
  • To discuss the evolving landscape of thrombotic disorder management.

Main Methods:

  • Review of recent clinical developments and ongoing trials.
  • Analysis of novel antithrombotic, anticoagulant, and thrombolytic drugs.

Related Experiment Videos

  • Discussion of biotechnology and advanced drug delivery systems.

    • Main Results:

    • Development of diverse antithrombotic agents (natural, synthetic, biotech-derived).
    • Emergence of drugs acting via novel mechanisms, not solely anticoagulation.
    • Recognition of the importance of pharmacodynamic actions and endogenous activation.
    • Involvement of hematologic and vascular modulation in therapeutic effects.

    Conclusions:

    • Optimal antithrombotic strategies require targeting multiple sites of thrombogenesis.
    • New drugs offer diverse mechanisms beyond traditional anticoagulation.
    • Combination therapies may be crucial for effective management of thrombotic disorders.
    • Biomedical device development also benefits from these advancements.